DeepMed Research

University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy

Not Applicable

Active, not recruiting

Conditions: Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis

Interventions: Behavioral: Remote monitoring

First Posted Date: 2022-04-07

Last Posted Date: 2024-08-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 123

Registration Number: NCT05316584

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

and more 2 locations

Palliative Care for Persons With ADRD and CI in SNF

Not Applicable

Completed

Conditions: Palliative Care
Cognitive Impairment
Advance Care Planning
Skilled Nursing Facility

Interventions: Other: Palliative Care Consultation

First Posted Date: 2022-04-01

Last Posted Date: 2024-12-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 7

Registration Number: NCT05308004

Locations: 🇺🇸
Acts Continuing Care Retirement Communities, Philadelphia, Pennsylvania, United States

Symptomatic Carotid Outcomes Registry

Recruiting

Conditions: Ischemic Stroke
Transient Ischemic Attack
Carotid Stenosis

Interventions: Other: intensive medical therapy

First Posted Date: 2022-03-29

Last Posted Date: 2025-05-15

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 114

Registration Number: NCT05300737

Locations: 🇺🇸
Hartford Hospital, Hartford, Connecticut, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

and more 14 locations

Dengue 4 Human Infection Model (Dengue CVD 11000; DHIM-4)

Phase 1

Completed

Conditions: Dengue

Interventions: Biological: Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - High Dose
Biological: Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose
Biological: Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Medium Dose
Biological: Dengue 4 Live Virus Human Challenge (DENV-4-LVHC) - Low Dose - Homologous Rechallenge

First Posted Date: 2022-03-07

Last Posted Date: 2025-04-17

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 20

Registration Number: NCT05268302

Locations: 🇺🇸
University of Maryland, Baltimore, Center for Vaccine Development and Global Health, Baltimore, Maryland, United States

The Utility of the Validated Intraoperative Bleeding Scale in Spine Surgery

Completed

Conditions: Thoracolumbar Spine Surgery
Intraoperative Blood Loss

First Posted Date: 2022-02-28

Last Posted Date: 2024-05-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 121

Registration Number: NCT05258487

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Time-Restricted Eating to Address Persistent Cancer-Related Fatigue

Not Applicable

Active, not recruiting

Conditions: Diet Therapy
Survivorship
Fasting, Intermittent
Fatigue
Neoplasms
Therapy
Time

Interventions: Behavioral: Healthy lifestyle education
Behavioral: Time-restricted eating

First Posted Date: 2022-02-25

Last Posted Date: 2025-05-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 50

Registration Number: NCT05256888

Locations: 🇺🇸
University of Maryland, Baltimore, Baltimore, Maryland, United States

Comparing Chemoprevention Approaches for School-based Malaria Control

Phase 4

Completed

Conditions: Malaria,Falciparum
Anemia in Children

Interventions: Drug: Dihydroartemisinin-Piperaquine
Drug: Chloroquine

First Posted Date: 2022-02-17

Last Posted Date: 2022-11-15

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 746

Registration Number: NCT05244954

Locations: 🇲🇼
Kamuzu University of Health Sciences, Blantyre, Malawi

TERPS Trial for de Novo Oligometastic Prostate Cancer

Phase 2

Recruiting

Conditions: Prostate Cancer
Oligometastatic Disease

Interventions: Radiation: Prostate radiation (XRT)
Drug: Systemic Therapy
Radiation: Stereotactic ablative radiation therapy (SABR)

First Posted Date: 2022-02-04

Last Posted Date: 2024-05-29

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 122

Registration Number: NCT05223803

Locations: 🇺🇸
UC San Diego Moores Cancer Center, La Jolla, California, United States
🇺🇸
Sidney Kimmel Cancer Center at Jefferson Health, Philadelphia, Pennsylvania, United States
🇺🇸
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

and more 6 locations

Luteolin for the Treatment of People With Schizophrenia

Not Applicable

Recruiting

Conditions: Schizoaffective Disorder
Schizophrenia

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Luteolin

First Posted Date: 2022-01-24

Last Posted Date: 2025-05-20

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 60

Registration Number: NCT05204407

Locations: 🇺🇸
Maryland Psychiatric Research Center, Baltimore, Maryland, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States

COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2

Completed

Conditions: COVID-19
SARS-CoV2 Infection

Interventions: Device: Novel point-of-care, semi-quantitative test for SARS-CoV-2 antibodies

First Posted Date: 2022-01-19

Last Posted Date: 2023-05-10

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 56

Registration Number: NCT05196932

Locations: 🇺🇸
University of Maryland Medical Systems, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy